After eleven 11 of survivorship, I’ve been waiting to hear the words, “You’re completely free of cancer! Go in peace,” but ...

Ongoing research within the advanced-stage melanoma therapeutic space is beginning to suggest that shorter treatment periods ...

Valarie Traynham sat down for an interview in CURE in which she discussed adjusting to life after cancer, detailing her ‘new normal.’ ...

Dr. Alexandra Zaleta discussed the impact of administrative delays and insurance red tape experienced by patients with ...

My cancer journey taught me that nothing is certain; however, with support, humor and acceptance, we can weather the ups and ...

In a phase 2 study, 52% of patients treated with Bria-IMT plus a checkpoint inhibitor for metastatic breast cancer were alive at one year.

Prehabilitation and early screening, including BIS, can ease recovery, reduce side effects and help manage lymphedema after ...

CURE®s’ news page brings patients, survivors, and caregivers everything they need to know when it comes to cancer news and important oncology updates.

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

Key Takeaways Cancer research funding involves federal, state, and private resources, with NIH and NCI as major contributors. Proposed 2026 budget cuts to NIH threaten progress in cancer research and ...

Key Takeaways The narrative draws parallels between childhood fears and the persistent anxiety of cancer recurrence, emphasizing the psychological impact on survivors. Despite being cancer-free for ...

Key Takeaways Tumor-infiltrating lymphocyte (TIL) therapy offers a novel approach for advanced melanoma, leveraging the patient's immune system for treatment-resistant cases. The FDA approved a ...